Anthony James Hatswell (Anthony J Hatswell, Anthony Hatswell)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Platelet Rich Plasma

Systematic Review

Health Information

Multiple Myeloma

Top Venues

PharmacoEconomics

Health economics

Applied health economics and health policy

Statistical methods in medical research

This page only lists publications with an associated author ORCID identifier.

Publications

Anthony James Hatswell, Mohammad A Chaudhary, Giles Monnickendam, Alejandro Moreno-Koehler, Katie Frampton, James W Shaw, John R Penrod, Rachael Lawrance
Modelling Health State Utilities as a Transformation of Time to Death in Patients with Non-Small Cell Lung Cancer. PharmacoEconomics (2023)
Paola Ghione, M Lia Palomba, Anik R Patel, Sabela Bobillo, Kevin Deighton, Caron A Jacobson, Myrna Nahas, Anthony James Hatswell, A Scott Jung, Steve Kanters, Julia Thornton Snider, Sattva S Neelapu, Maria Teresa Ribeiro, M Alan Brookhart, Herve Ghesquieres, John Radford, John G Gribben
Comparative effectiveness of ZUMA-5 (axi-cel) vs SCHOLAR-5 external control in relapsed/refractory follicular lymphoma. Blood 140 (8) (2022)
Rebekah Pennington, Jack Eaton, Anthony James Hatswell, Helen Taylor
Carers' Health-Related Quality of Life in Global Health Technology Assessment: Guidance, Case Studies and Recommendations. PharmacoEconomics 40 (9) (2022)
Anthony James Hatswell, Kevin Deighton, Julia Thornton Snider, M Alan Brookhart, Imi Faghmous, Anik R Patel
Approaches to Selecting "Time Zero" in External Control Arms with Multiple Potential Entry Points: A Simulation Study of 8 Approaches. Medical decision making : an international journal of the Society for Medical Decision Making 42 (7) (2022)
Anthony James Hatswell, Nick Freemantle, Gianluca Baio, Emmanuel Lesaffre, Joost van Rosmalen
Summarising salient information on historical controls: A structured assessment of validity and comparability across studies. Clinical trials (London, England) 17 (6) (2020)
Ash Bullement, Matthew Taylor, Sam Thomas McMordie, Errol Waters, Anthony James Hatswell
NICE, in Confidence: An Assessment of Redaction to Obscure Confidential Information in Single Technology Appraisals by the National Institute for Health and Care Excellence. PharmacoEconomics 37 (11) (2020)
Anthony James Hatswell, Ash Bullement, Michael Schlichting, Murtuza Bharmal
What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches. Applied health economics and health policy 19 (3) (2020)
Christopher James Sampson, Renée J G Arnold, Stirling Bryan, Philip M Clarke, Sean Ekins, Anthony James Hatswell, Neil Hawkins, Sue Langham, Deborah A Marshall, J Mark FitzGerald, William G Sullivan, Edward C F Wilson, Tim Wrightson
Transparency in Decision Modelling: What, Why, Who and How? PharmacoEconomics 37 (11) (2020)
Ash Bullement, Tanja Podkonjak, Mark J Robinson, Eugene Benson, Ross Selby, Anthony James Hatswell, Gemma Elizabeth Shields
Real-world evidence use in assessments of cancer drugs by NICE. International journal of technology assessment in health care (2020)
Anthony James Hatswell, Darren Burns, Gianluca Baio, Frances Wadelin
Frequentist and Bayesian meta-regression of health state utilities for multiple myeloma incorporating systematic review and analysis of individual patient data. Health economics 28 (5) (2019)
Anthony James Hatswell, William G Sullivan
Creating historical controls using data from a previous line of treatment - Two non-standard approaches. Statistical methods in medical research 29 (6) (2019)